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Pursuant to P.L. 2017, ch. 429, the Bureau of Insurance is required to report to the Maine Legislature’s 
Committee on Health Coverage, Insurance and Financial Services on any changes made by carriers, or 
any Pharmacy Benefits Manager contracted by carriers, to any prescription drug formulary for a health 
plan offered between January 1, 2019 and December 31, 2019.  
 
24-A M.R.S. § 4311 B-1 states: 
Sec. B-1. Report on formulary changes. As determined by the Department of Professional and 
Financial Regulation, Bureau of Insurance, a carrier subject to the requirements of the Maine 
Revised Statutes, Title 24-A, section 4311, subsection 1 shall report quarterly no less than 30 
days following the end of each quarter on any changes made by the carrier or any pharmacy 
benefits manager contracted by the carrier to any prescription drug formulary for a health plan 
offered in this State between January 1, 2019 and December 31, 2019. For purposes of this 
section, a change to a prescription drug formulary includes the movement of a prescription drug 
to a tier with higher cost sharing for that drug or the removal of a prescription drug from the 
formulary. The report must be in a form and manner determined by the Bureau of Insurance and 
include a list of formulary changes made by the carrier and the effective date of each formulary 
change; the prescription drugs affected by each formulary change by name and manufacturer; 
the number of enrollees affected by each formulary change; the expected impact of each 
formulary change on cost sharing for affected enrollees; a written explanation of the reasons for 
each formulary change; the number of exception requests made by enrollees with regard to each 
formulary change; and the number of exception requests granted, denied or withdrawn with 
regard to each formulary change.  (Emphasis added.)  No less than 60 days following the end of 
each quarter, as determined by the Bureau of Insurance, the bureau shall compile this data for 
those carriers required by the bureau to report and submit a report to the joint standing 
committee of the Legislature having jurisdiction over insurance and financial services matters. 
The joint standing committee of the Legislature having jurisdiction over insurance and financial 
services matters may report out legislation related to the report to any regular or special session 
of the 129th Legislature. 
 
The information published in this report is based upon the self-reported data furnished by insurance 
companies to the Bureau of Insurance.   All carriers that use a formulary were surveyed.  This included 
the 6 largest carriers in Maine and the largest prescription TPA:  Anthem, Aetna, Community Health 
Options, Cigna, Harvard Pilgrim/HPHC, United and Express Scripts.  Those carriers, the Bureau of 
Insurance and the State of Maine Employee Health Benefits Department worked together to develop 
the form used to gather the required data.  
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Summary for the first quarter of 2019: 
 
• 329 drugs were subject to formulary changes (excluding duplicative drugs due to various 
dosages or dispensing type, there are 196 drugs). 
 
• Approximately half the changes were to add new drugs.  Almost a quarter of the 
changes were to remove drugs. 
 
• These changes affected 377 enrollees.   
 
• Of these enrollees, 51% (193) filed for exceptions.  52% were granted; 48% were denied. 
 
• 23% of enrollees were impacted by lower or no change in cost; 11 % by higher costs and 




Table 1:  Changes made on the 329 drugs listed for Q1 2019 
Change Made Number of Drugs Affected 
Add drugs  158 
Remove drugs 55 
Add prior authorization 45 
Move drug to higher tier 21 
Add quantity limit 19 
Add step therapy 14 
Move drug to lower tier 10 
Drug becomes over the counter 6 






Table 2:  Top drugs changed for Q1 2019    
Drug Number of Changes 





Vitamin D is used to treat and prevent bone disorders (such as rickets, osteomalacia). Vitamin D is made 
by the body when skin is exposed to sunlight. Sunscreen, protective clothing, limited exposure to 
sunlight, dark skin, and age may prevent getting enough vitamin D from the sun. 
 
Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the 
mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication 
is also used to treat outbreaks of genital herpes. 
 
Tirosint (levothyroxine sodium) is a replacement for a hormone that is normally produced by your 
thyroid gland to regulate the body's energy and metabolism used to treat hypothyroidism (low thyroid 
hormone). 
 
Focalin (dexmethylphenidate) is a mild stimulant to the central nervous system. It affects chemicals in 
the brain that contribute to hyperactivity and impulse control. Focalin is used to treat attention deficit 
hyperactivity disorder (ADHD). Focalin may also be used for purposes not listed in this medication guide. 
 
Table 3:  Number of enrollees the changes affected for Q1 2019 
Change Number of Affected Enrollees 
Add drugs 0 
Remove drugs 211 
Add prior authorization 36 
Move drug to higher tier 43 
Add quantity limit 33 
Add step therapy 14 
Move drug to lower tier 0 
Drug becomes over the counter 39 
Decrease quantity limit 1 





Table 4:  Expected impact and the number of enrollees affected by the impact for Q1 2019 
Expected Impact Number of Affected Enrollees 
Responsible for full cost of drug * 250 
No change 86 
Higher cost 41 
Lower cost 0 
Total 377 
 
*Results from removal of drug from formulary, which could result in higher cost to enrollee if they do not 
change to a different drug. 
 
23% of enrollees are impacted by lower or no change in cost 
11% of enrollees are impacted by higher costs or 
77% of enrollees are impacted by higher costs (if they continue to use the removed drug from formulary) 
 
 
Table 5:  Number of enrollees affected by the formulary changes, number of exceptions 
requested, granted, denied and withdrawn  










377 193 100 93 0 
 
51% of all enrollees affected filed for exceptions: 
52% granted, 48% denied 
 
Table 6:  Number of exceptions granted and denied by change made in Q1 2019 
Change Made Granted  Denied 
Add drugs 0 0 
Remove drugs 33 66 
Add prior authorization 58 12 
Move drug to higher tier 3 1 
Add quantity limit 0 9 
Add step therapy 6 5 
Move drug to lower tier 0 0 
Drug becomes over the counter 0 0 
Decrease quantity limit 0 0 






Table 7:  Reasons given by carriers for the changes for Q1 2019. 
Formulary Change Reasons  Total Drugs per Reason 
Added Upon Release to Market  205 
Business Decision Team Decision-generic equivalent  131 
To ensure clinically appropriate usage of drug  36 
Business Decision Team Decision to exclude drug from formulary  30 
Business Decision Team Decision to add Prior Authorization  27 
Business Decision Team Decision to add Quantity Limits  18 
To ensure clinically appropriate dosage of drug  17 
Additional therapy option for enrollees  17 
Generic version approved and added at lower tier  16 
Clinically appropriate alternatives on formulary   11 
Lower cost option for enrollees  10 
AB rated (therapeutically equivalent) substitutable  8 
Medication not approved by FDA as a drug  6 
Business Decision Team Decision to move   3 
Multisource brand (MSB) removal  2 
Promote appropriate use and minimize overuse/waste  1 
Anesthesia medication that must be administered by MD  1 
To encourage appropriate use of preferred agents  4 
Total  543 
Table 8:    Changes Made by Drug Name Q1 2019   
Drug Name Change Made 
ABACAVIR SOLN MOVE DRUG TO LOWER TIER 
ABACAVIR TAB 300MG MOVE DRUG TO LOWER TIER 
ABILIFY MYCITE ADD STEP THERAPY 
ABLYSINOL 99% AMPULE ADD DRUGS 
ACETAMINOPHEN-CODEINE 120-12 MG, 300-30 MG SOLUTIONI ADD PRIOR AUTHORIZATION 
ACYCLOVIR 5% CREAM ADD DRUGS 
ACYCLOVIR 5% OINTMENT REMOVE DRUGS 
ACZONE 7.5% GEL PUMP REMOVE DRUGS 
ADDERALL XR 10 MG CAPSULE REMOVE DRUGS 
ADDERALL XR 15 MG CAPSULE REMOVE DRUGS 
ADDERALL XR 20 MG CAPSULE REMOVE DRUGS 
ADDERALL XR 25 MG CAPSULE REMOVE DRUGS 
ADDERALL XR 30 MG CAPSULE REMOVE DRUGS 
AEMCOLO DR 194 MG TABLET ADD DRUGS 
AFREZZA 90-8 UNIT / 90-12 UNIT ADD DRUGS 
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AFREZZA 90-8 UNIT / 90-12 UNIT ADD PRIOR AUTHORIZATION 
AFREZZA 90-8 UNIT / 90-12 UNIT ADD QUANTITY LIMIT 
ALBUMINAR-25 IV SOLUTION ADD DRUGS 
ALBUTEROL SUL HFA 90 MCG INH ADD DRUGS 
ALISKIREN 150 MG TABLET ADD DRUGS 
ALISKIREN 300 MG TABLET ADD DRUGS 
ALTOPREV ADD STEP THERAPY 
ALYQ 20 MG TABLET ADD DRUGS 
AMICAR 1,000 MG TABLET REMOVE DRUGS 
AMICAR 500 MG TABLET REMOVE DRUGS 
AMINO ACID 50 G/1,000 ML-NS ADD DRUGS 
AMINOPROTECT 25-25 G/1,000 ML ADD DRUGS 
ANDEXXA 200 MG VIAL ADD DRUGS 
APADAZ 4.08-325 MG TABLET ADD DRUGS 
APADAZ 6.12-325 MG TABLET ADD DRUGS 
APADAZ 8.16-325 MG TABLET ADD DRUGS 
APRISO ADD STEP THERAPY 
APTIOM 400 MG TABLET ADD PRIOR AUTHORIZATION 
ASCOMP WITH CODEINE CAPSULE ADD PRIOR AUTHORIZATION 
AUBAGIO TAB 14MG, 7MG REMOVE DRUGS 
AXUMIN 10 MCI (370 MBQ) VIAL ADD DRUGS 
AZELEX 20% CREAM REMOVE DRUGS 
BACLOFEN 10 MG/20 ML VIAL ADD DRUGS 
BACLOFEN 20,000 MCG/20 ML VIAL ADD DRUGS 
BACLOFEN 40 MG/20 ML VIAL ADD DRUGS 
BALSAM PERU-CASTOR OIL OINT ADD DRUGS 
BENZHYDROCOD-ACETAMIN 4.08-325 ADD DRUGS 
BENZHYDROCOD-ACETAMIN 6.12-325 ADD DRUGS 
BENZHYDROCOD-ACETAMIN 8.16-325 ADD DRUGS 
BETAMETHASONE SP-AC 30 MG/5 ML ADD DRUGS 
BIJUVA 1 MG-100 MG CAPSULE ADD DRUGS 
BIKTARVY 50-200-25 MG TABLET MOVE DRUG TO LOWER TIER 
BIKTARVY TAB ADD DRUGS 
BPCO REMOVE DRUGS 
BRIVIACT 100 MG TABLET ADD PRIOR AUTHORIZATION 
BRIVIACT 25 MG TABLET ADD PRIOR AUTHORIZATION 
BUPRENO-NALOX 2-0.5 MG SL FILM ADD DRUGS 
BUPRENOR-NALOX 12-3 MG SL FILM ADD DRUGS 
BUPRENORP-NALOX 4-1 MG SL FILM ADD DRUGS 
BUTALBITAL-CAFFEINE-ACETAMINOPHEN-CODEINE CAPSULE ADD PRIOR AUTHORIZATION 
BYETTA 10 MCG DOSE PEN INJ ADD QUANTITY LIMIT 
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BYETTA 5 MCG DOSE PEN INJ ADD QUANTITY LIMIT 
CABLIVI 11 MG KIT ADD DRUGS 
CALCIUM GLUC 1,000MG/50ML-NACL ADD DRUGS 
CEFAZOLIN 3 GRAM/100 ML-D5W ADD DRUGS 
CHERATUSSIN AC ADD PRIOR AUTHORIZATION 
CINACALCET HCL 30 MG TABLET ADD DRUGS 
CINACALCET HCL 30MG, 60MG, 90MG TABLET ADD DRUGS 
CINACALCET HCL 60 MG TABLET ADD DRUGS 
CINACALCET HCL 90 MG TABLET ADD DRUGS 
CINVANTI ADD PRIOR AUTHORIZATION 
CLINDAMYCIN GEL ADD STEP THERAPY 
CLINDAMYCIN LOT ADD STEP THERAPY 
CLOBETASOL PROPIONATE E ADD STEP THERAPY 
CLOBETASOL SOL ADD STEP THERAPY 
CODEINE SULFATE 15 MG, 30 MG, 60 MG ADD PRIOR AUTHORIZATION 
COLCHICINE TAB 0.6MG ADD DRUGS 
COLCHICINE TAB 0.6MG ADD PRIOR AUTHORIZATION 
CONCERTA ER 18 MG TABLET REMOVE DRUGS 
CONCERTA ER 27 MG TABLET REMOVE DRUGS 
CONCERTA ER 36 MG TABLET REMOVE DRUGS 
CONCERTA ER 54 MG TABLET REMOVE DRUGS 
CUPRIMINE 250 MG CAPSULE ADD PRIOR AUTHORIZATION 
DAURISMO ADD PRIOR AUTHORIZATION 
DAURISMO ADD QUANTITY LIMIT 
DAYTRANA 10 MG/9 HR PATCH ADD PRIOR AUTHORIZATION 
DAYTRANA 30 MG/9 HOUR PATCH ADD PRIOR AUTHORIZATION 
DENAVIR 1% CREAM REMOVE DRUGS 
DERM-SILK 2"X5.5" PAD ADD DRUGS 
DERMUCLERA REMOVE DRUGS 
DESFLURANE INHALATION LIQUID ADD DRUGS 
DEXCHLORPHENIRAMINE 2 MG/5 ML ADD DRUGS 
DEXILANT DR 30 MG CAPSULE ADD QUANTITY LIMIT 
DIDANOSINE DR CAP 250MG, 400MG, 125MG, 200MG MOVE DRUG TO LOWER TIER 
DIGOXIN MICRONIZED POWDER ADD DRUGS 
DIVIGEL 0.75 MG GEL PACKET ADD DRUGS 
DOTAREM 2.5 MMOL/5 ML VIAL ADD DRUGS 
D-PENAMINE 125 MG TABLET ADD DRUGS 
DSUVIA 30 MCG SUBLINGUAL TAB ADD DRUGS 
ELIDEL MOVE DRUG TO HIGHER TIER 
ELZONRIS 1,000 MCG/ML VIAL ADD DRUGS 
EMGALITY 120 MG/ML SYRINGE ADD DRUGS 
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EPCLUSA TAB REMOVE DRUGS 
EPICYN FACIAL CLEANSER SPRAY ADD DRUGS 
EPIDUO FORTE 0.3-2.5% GEL PUMP REMOVE DRUGS 
EPIPEN JR REMOVE DRUGS 
EPTIFIBATIDE 75 MG/100 ML BAG ADD DRUGS 
ERBITUX SOLN ADD DRUGS 
ERBITUX SOLN ADD PRIOR AUTHORIZATION 
ESOMEPRAZOLE MAG DR 20 MG CAP ADD QUANTITY LIMIT 
FABIOR 0.1% FOAM REMOVE DRUGS 
FARESTON 60MG MOVE DRUG TO HIGHER TIER 
FARESTON 60MG TABLET MOVE DRUG TO HIGHER TIER 
FIRDAPSE ADD QUANTITY LIMIT 
FIRDAPSE 10 MG TABLET ADD DRUGS 
FLECTOR 1.3% TRANSERMAL PATCH MOVE DRUG TO HIGHER TIER 
FLOWTUSS SOLN ADD DRUGS 
FLUTICASONE-SALMETEROL 100-50 ADD DRUGS 
FLUTICASONE-SALMETEROL 250-50 ADD DRUGS 
FLUTICASONE-SALMETEROL 500-50 ADD DRUGS 
FOCALIN XR 15 MG CAPSULE REMOVE DRUGS 
FOCALIN XR 20 MG CAPSULE REMOVE DRUGS 
FOCALIN XR 30 MG CAPSULE REMOVE DRUGS 
FOCALIN XR 40 MG CAPSULE REMOVE DRUGS 
FYCOMPA 2 MG TABLET ADD PRIOR AUTHORIZATION 
GAMIFANT 10 MG/2 ML VIAL ADD DRUGS 
GAMIFANT 50 MG/10 ML VIAL ADD DRUGS 
GEL-FLOW NT SYRINGE ADD DRUGS 
GLATIRAMER INJ 40MG/ML ADD DRUGS 
GLATIRAMER INJ 40MG/ML ADD PRIOR AUTHORIZATION 
GLATOPA INJ 40MG/ML ADD DRUGS 
GLATOPA INJ 40MG/ML ADD PRIOR AUTHORIZATION 
GLYCOPYRROLATE 0.2 MG/ML SYRNG ADD DRUGS 
GLYCOPYRROLATE 0.4 MG/2 ML SYR ADD DRUGS 
GUAIFENESIN-CODEINE LIQUID ADD PRIOR AUTHORIZATION 
GUAITUSSIN AC LIQUID ADD PRIOR AUTHORIZATION 
HAILEY 24 FE 1 MG-20 MCG TAB ADD DRUGS 
HALOBETASOL AER 0.05% ADD STEP THERAPY 
HALOBETASOL PROP 0.05% FOAM ADD DRUGS 
HARVONI REMOVE DRUGS 
HEXALEN ADD PRIOR AUTHORIZATION 
HIDEX 6 DAY 1.5 MG TABLET ADD DRUGS 
HUMIRA MOVE DRUG TO HIGHER TIER 
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HUMIRA PEN MOVE DRUG TO HIGHER TIER 
HYDROMORPHONE 1 MG/ML-WATER ADD DRUGS 
INBRIJA 42 MG INHALATION CAP ADD DRUGS 
INNOSPIRE GO NEBULIZER ADD DRUGS 
INVOKANA MOVE DRUG TO HIGHER TIER 
JASMIEL 3 MG-0.02 MG TABLET ADD DRUGS 
KELOTOP 4.7"X5.7" SHEET ADD DRUGS 
KEPPRA 250 MG TABLET REMOVE DRUGS 
KEPPRA 500 MG TABLET REMOVE DRUGS 
KEPPRA XR 500 MG TABLET REMOVE DRUGS 
KETAMINE 100 MG/10 ML-NACL SYR ADD DRUGS 
KRINTAFEL ADD QUANTITY LIMIT 
KRINTAFEL 150 MG TABLET ADD DRUGS 
LAMICTAL 200 MG TABLET REMOVE DRUGS 
LAMIVUDINE TAB 150MG, 300MG MOVE DRUG TO LOWER TIER 
LEVICYN SOL DERMAL REMOVE DRUGS 
LEVORPHANOL 3 MG TABLET ADD DRUGS 
LEVORPHANOL 3 MG TABLET ADD PRIOR AUTHORIZATION 
LEVORPHANOL 3 MG TABLET ADD QUANTITY LIMIT 
LEVORPHANOL 3MG TABLET ADD QUANTITY LIMIT 
LIDOCAINE 0.5MG INTRADERM SYST ADD DRUGS 
LIDOCAINE 50 MG/5 ML (1%) SYRG ADD DRUGS 
LIOTHYRONINE SOD 1:1000 DILUTN ADD DRUGS 
LIPIODOL 4.8 GM/10 ML AMPUL ADD DRUGS 
LIQUIVIDA HYDRATION KIT ADD DRUGS 
LIVALO 1 MG TABLET REMOVE DRUGS 
LIVALO 2 MG TABLET REMOVE DRUGS 
LIVALO 4 MG TABLET REMOVE DRUGS 
LOPINAVIR-RITONAVIR SOLN MOVE DRUG TO LOWER TIER 
LORBRENA ADD PRIOR AUTHORIZATION 
LORBRENA ADD QUANTITY LIMIT 
LOTEMAX SM 0.38% OPHTH GEL ADD DRUGS 
MEPERIDINE INJ ADD DRUGS 
MESALAMINE 1,000 MG SUPP ADD DRUGS 
MESTINON SYRUP 60MG/5ML MOVE DRUG TO HIGHER TIER 
METFORMIN ER TAB 500MG, 1000MG (GENERIC FORTAMET 
ONLY) 
REMOVE DRUGS 
MINOCYCLINE ER 105 MG TABLET ADD DRUGS 
MINOCYCLINE ER 80 MG TABLET ADD DRUGS 
MITOXANTRONE 2MG/ML ADD DRUGS 
MORPHINE 1MG/2ML SYRINGE ADD QUANTITY LIMIT 
MOTEGRITY ADD PRIOR AUTHORIZATION 
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MOTEGRITY ADD QUANTITY LIMIT 
MOXIFLOXACIN TAB 400MG ADD DRUGS 
MULPLETA ADD PRIOR AUTHORIZATION 
MULPLETA ADD QUANTITY LIMIT 
NEVIRAPINE TAB 200MG; SOLN 50MG MOVE DRUG TO LOWER TIER 
NEXIUM ADD STEP THERAPY 
NIVESTYM 300 MCG/ML VIAL ADD DRUGS 
NIVESTYM 480 MCG/1.6 ML VIAL ADD DRUGS 
NUCYNTA TAB 50MG, 75MG 100MG REMOVE DRUGS 
NUZYRA 100 MG VIAL ADD DRUGS 
NUZYRA 150 MG TABLET ADD DRUGS 
NUZYRA 150 MG TABLET-7 DAY ADD DRUGS 
NUZYRA 150 MG-7 DAY WITH LOAD ADD DRUGS 
OMNIPAQUE 9 MG/ML ORAL SOLN ADD DRUGS 
ORFADIN 2 MG, 5 MG, 10 MG, 20 MG ADD PRIOR AUTHORIZATION 
OXAZEPAM CAP 10MG, 15MG, 30MG ADD DRUGS 
OXYCONTIN TAB 10MG, 15MG, 20MG, 30MG, 40MG, 60MG, 
80MG 
REMOVE DRUGS 
OZEMPIC INJ ADD DRUGS 
OZEMPIC INJ ADD STEP THERAPY 
PARSABIV ADD PRIOR AUTHORIZATION 
PENLEN SPRAY EMULSION ADD DRUGS 
PIMECROLIMUS 1% CREAM ADD DRUGS 
POTASSIUM CL 20MEQ/100ML-WATER ADD DRUGS 
PRALUENT 150 MG/ML PEN REMOVE DRUGS 
PRALUENT 75 MG/ML PEN REMOVE DRUGS 
PRODIGEN CAPSULES REMOVE DRUGS 
PROGRAF 1 MG CAPSULE MOVE DRUG TO HIGHER TIER 
PROMACTA 12.5 MG SUSPEN PACKET ADD DRUGS 
PROMETHAZINE-CODEINE SYRUP ADD PRIOR AUTHORIZATION 
PROMETHAZINE-PE-CODEINE SYRUP ADD PRIOR AUTHORIZATION 
PROTHELIAL 1 GM/10 ML PASTE ADD DRUGS 
PROVAD CAPSULES REMOVE DRUGS 
PYRIDOSTIGMINE 60 MG/5 ML SOLN ADD DRUGS 
QBREXZA ADD PRIOR AUTHORIZATION 
QBREXZA ADD QUANTITY LIMIT 
QUILLICHEW ER 20 MG CHEW TAB REMOVE DRUGS 
QUILLICHEW ER 40 MG CHEW TAB REMOVE DRUGS 
RANEXA 1000MG TABLET MOVE DRUG TO HIGHER TIER 
RANEXA 500MG TABLET MOVE DRUG TO HIGHER TIER 
RANOLAZINE ER 1,000 MG TABLET ADD DRUGS 
RANOLAZINE ER 500 MG TABLET ADD DRUGS 
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RAPAMUNE SOLUTION 1MG/1ML MOVE DRUG TO HIGHER TIER 
RELPAX ADD STEP THERAPY 
RENAGEL 400MG MOVE DRUG TO HIGHER TIER 
RENAGEL 400MG TABLET MOVE DRUG TO HIGHER TIER 
RENAGEL 800MG MOVE DRUG TO HIGHER TIER 
RENAGEL 800MG TABLET MOVE DRUG TO HIGHER TIER 
RESTASIS REMOVE DRUGS 
RETAVASE VIAL FULL KIT ADD DRUGS 
RETAVASE VIAL HALF-KIT ADD DRUGS 
RETIN-A MICRO PUMP 0.06% GEL REMOVE DRUGS 
ROPIVACAINE 0.2% 200 MG/100 ML ADD DRUGS 
ROPIVACAINE 0.2% 400 MG/200 ML ADD DRUGS 
ROPIVACAINE 0.2%-NACL BAG ADD DRUGS 
SABRIL 500MG MOVE DRUG TO HIGHER TIER 
SENSIPAR ADD PRIOR AUTHORIZATION 
SEVELAMER HCL 400 MG TABLET ADD DRUGS 
SEVELAMER HCL 800 MG TABLET ADD DRUGS 
SIROLIMUS 1 MG/ML SOLUTION ADD DRUGS 
SODIUM BICRB 150 MEQ/1,000-D5W ADD DRUGS 
SODIUM PHOS 15 MMOL/100 ML-NS ADD DRUGS 
SOVALDI TAB 400MG REMOVE DRUGS 
SPRAVATO 56 MG DOSE PACK ADD DRUGS 
SPRAVATO 84 MG DOSE PACK ADD DRUGS 
STAVUDINE CAP 15MG, 20MG, 30MG, 40MG, SOLN 1MG MOVE DRUG TO LOWER TIER 
STAVUDINE CAP SOLN 1MG MOVE DRUG TO LOWER TIER 
STELARA INJ 90MG DECREASE QUANTITY LIMIT 
SUPRANE INHALATION REMOVE DRUGS 
SURGIFOAM SPONGE SIZE 100C ADD DRUGS 
SURGIFOAM SPONGE SIZE 12-7 ADD DRUGS 
SYMJEPI ADD QUANTITY LIMIT 
SYMJEPI ADD STEP THERAPY 
TAPERDEX 7 DAY 1.5 MG TAB PACK ADD DRUGS 
TAZORAC 0.05% CREAM REMOVE DRUGS 
TAZORAC 0.1% CREAM REMOVE DRUGS 
TECHNIVIE TAB REMOVE DRUGS 
TEKTURNA 150MG MOVE DRUG TO HIGHER TIER 
TEKTURNA 300MG MOVE DRUG TO HIGHER TIER 
TIROSINT 175 MCG CAPSULE ADD DRUGS 
TIROSINT 200 MCG CAPSULE ADD DRUGS 
TIROSINT-SOL 100 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 112 MCG/ML SOLN ADD DRUGS 
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TIROSINT-SOL 125 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 13 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 137 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 150 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 175 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 200 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 25 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 50 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 75 MCG/ML SOLN ADD DRUGS 
TIROSINT-SOL 88 MCG/ML SOLN ADD DRUGS 
TOLSURA 65 MG CAPSULE ADD DRUGS 
TOREMIFENE CITRATE 60 MG TAB ADD DRUGS 
TREPROSTINIL 100 MG/20 ML VIAL ADD DRUGS 
TREPROSTINIL 20 MG/20 ML VIAL ADD DRUGS 
TREPROSTINIL 200 MG/20 ML VIAL ADD DRUGS 
TREPROSTINIL 50 MG/20 ML VIAL ADD DRUGS 
TRILEPTAL 300 MG TABLET REMOVE DRUGS 
TRISODIUM CITRAT CRRT 0.5% SOL ADD DRUGS 
TRI-VYLIBRA LO TABLET ADD DRUGS 
TROKENDI XR ADD STEP THERAPY 
TUXARIN ER 8-54.3 MG TABLET ADD DRUGS 
TUXARIN ER TAB ADD PRIOR AUTHORIZATION 
TUXARIN ER TAB ADD QUANTITY LIMIT 
TUZISTRA XR ADD PRIOR AUTHORIZATION 
ULTOMIRIS ADD PRIOR AUTHORIZATION 
ULTOMIRIS 300 MG/30 ML VIAL ADD DRUGS 
VANCOMYCIN 1 GRAM/200 ML BAG ADD DRUGS 
VANCOMYCIN 1.5 GRAM/300 ML BAG ADD DRUGS 
VANCOMYCIN HCL 1.25 GRAM VIAL ADD DRUGS 
VASHE CLEANS SOLUTION REMOVE DRUGS 
VIEKIRA PAK REMOVE DRUGS 
VIGABATRIN 500 MG TABLET ADD DRUGS 
VIMPAT 100 MG TABLET ADD PRIOR AUTHORIZATION 
VIMPAT 150 MG TABLET ADD PRIOR AUTHORIZATION 
VIMPAT 200 MG TABLET ADD PRIOR AUTHORIZATION 
VIRAMUNE SUSPENSION 50MG/5ML MOVE DRUG TO HIGHER TIER 
VIRTUSSIN AC ADD PRIOR AUTHORIZATION 
VITAMIN D3 1000 UNIT TABLET 
DRUG BECOMES OVER THE 
COUNTER 
VITAMIN D3 2000 UNIT SOFTGEL 




VITAMIN D3 2000 UNIT TABLET 
DRUG BECOMES OVER THE 
COUNTER 
VITAMIN D3 400 UNIT TAB CHEW 
DRUG BECOMES OVER THE 
COUNTER 
VITAMIN D3 400 UNIT TABLET 
DRUG BECOMES OVER THE 
COUNTER 
VITAMIN D3 50000 UNITS CAPS 
DRUG BECOMES OVER THE 
COUNTER 
VITRAKVI ADD PRIOR AUTHORIZATION 
VITRAKVI ADD QUANTITY LIMIT 
VIVITROL REMOVE DRUGS 
VOSEVI TAB ADD DRUGS 
VOSEVI TABLET ADD PRIOR AUTHORIZATION 
VYVANSE CHEW TAB 10MG, 20MG, 30MG, 40MG, 50MG, 60MG ADD DRUGS 
VYVANSE CHEW TAB 10MG, 20MG, 30MG, 40MG, 50MG, 60MG ADD PRIOR AUTHORIZATION 
WIXELA 100-50 INHUB ADD DRUGS 
WIXELA 250-50 INHUB ADD DRUGS 
WIXELA 500-50 INHUB ADD DRUGS 
XEROSTOMIA RELIEF SPRAY ADD DRUGS 
XIIDRA ADD DRUGS 
XIIDRA ADD PRIOR AUTHORIZATION 
XOFLUZA 20 MG TABLET ADD DRUGS 
XOFLUZA 40 MG TABLET ADD DRUGS 
XOFLUZA TAB 20MG, 40MG ADD DRUGS 
XOSPATA ADD PRIOR AUTHORIZATION 
XOSPATA ADD QUANTITY LIMIT 
YUPELRI ADD QUANTITY LIMIT 
YUTIQ 0.18 MG IMPLANT ADD DRUGS 
ZIDOVUDINE SYRUP 10MG; CAP 100MG, TAB 300MG MOVE DRUG TO LOWER TIER 
ZOLEDRONIC ACID 4 MG/100 ML ADD DRUGS 
ZOLEDRONIC ACID 4 MG/100 ML ADD PRIOR AUTHORIZATION 
ZOMIG ADD STEP THERAPY 
Table 9:  Number of affected enrollees by drug name Q1 2019: 
Drug Name Affected 
Enrollees 
ACYCLOVIR 5% OINTMENT 45 
ACZONE 7.5% GEL PUMP 12 
ADDERALL XR 10 MG CAPSULE 9 
ADDERALL XR 15 MG CAPSULE 3 
ADDERALL XR 20 MG CAPSULE 9 
ADDERALL XR 25 MG CAPSULE 3 
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ADDERALL XR 30 MG CAPSULE 12 
ALTOPREV 1 
APRISO 1 
APTIOM 400 MG TABLET 3 
AZELEX 20% CREAM 6 
BRIVIACT 100 MG TABLET 3 
BRIVIACT 25 MG TABLET 3 
BYETTA 10 MCG DOSE PEN INJ 12 
BYETTA 5 MCG DOSE PEN INJ 6 
CLINDAMYCIN GEL 2 
CLINDAMYCIN LOT 1 
CLOBETASOL PROPIONATE E 1 
CLOBETASOL SOL 2 
CONCERTA ER 18 MG TABLET 3 
CONCERTA ER 27 MG TABLET 3 
CONCERTA ER 36 MG TABLET 3 
CONCERTA ER 54 MG TABLET 3 
DAYTRANA 10 MG/9 HR PATCH 9 
DAYTRANA 30 MG/9 HOUR PATCH 6 
DENAVIR 1% CREAM 9 
DEXILANT DR 30 MG CAPSULE 3 
ELIDEL 1 
EPIDUO FORTE 0.3-2.5% GEL PUMP 9 
ESOMEPRAZOLE MAG DR 20 MG CAP 12 
FABIOR 0.1% FOAM 3 
FARESTON 60mg tablet 1 
FLECTOR 1.3% transdermal patch 1 
FOCALIN XR 15 MG CAPSULE 3 
FOCALIN XR 20 MG CAPSULE 3 
FOCALIN XR 30 MG CAPSULE 12 
FOCALIN XR 40 MG CAPSULE 3 
FYCOMPA 2 MG TABLET 3 
HUMIRA 1 
HUMIRA PEN 4 
INVOKANA 4 
KEPPRA 250 MG TABLET 3 
KEPPRA 500 MG TABLET 3 
KEPPRA XR 500 MG TABLET 3 
LAMICTAL 200 MG TABLET 3 
LIVALO 1 MG TABLET 6 
LIVALO 2 MG TABLET 6 
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LIVALO 4 MG TABLET 6 
NEXIUM 2 
PRALUENT 150 MG/ML PEN 3 
PRALUENT 75 MG/ML PEN 6 
PROGRAF 1 MG CAPSULE 18 
QUILLICHEW ER 20 MG CHEW TAB 3 
QUILLICHEW ER 40 MG CHEW TAB 3 
RANEXA 1000mg tablet 2 
RANEXA 500mg tablet 11 
RELPAX 1 
RETIN-A MICRO PUMP 0.06% GEL 3 
STELARA INJ 90MG 1 
TAZORAC 0.05% CREAM 3 
TAZORAC 0.1% CREAM 3 
TRILEPTAL 300 MG TABLET 3 
TROKENDI XR 2 
VIMPAT 100 MG TABLET 3 
VIMPAT 150 MG TABLET 3 
VIMPAT 200 MG TABLET 3 
VITAMIN D3 1000 UNIT TABLET 9 
VITAMIN D3 2000 UNIT SOFTGEL 12 
VITAMIN D3 2000 UNIT TABLET 6 
VITAMIN D3 400 UNIT TAB CHEW 3 
VITAMIN D3 400 UNIT TABLET 3 




Table 10:  Number of exceptions made by drug name Q1 2019:   
Drug Name Granted Denied Withdrawn Total 
Exception 
Requests 
ACYCLOVIR 5% OINTMENT 0 15 0 15 
ACZONE 7.5% GEL PUMP 0 3 0 3 
ADDERALL XR 10 MG CAPSULE 0 3 0 3 
ADDERALL XR 15 MG CAPSULE 3 3 0 6 
ADDERALL XR 20 MG CAPSULE 0 12 0 12 
ADDERALL XR 30 MG CAPSULE 0 3 0 3 
AFREZZA 90-8 UNIT / 90-12 UNIT 1 0 0 1 
ALTOPREV 0 1 0 1 
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ASCOMP WITH CODEINE CAPSULE 0 1 0 1 
AZELEX 20% CREAM 3 3 0 6 
BRIVIACT 100 MG TABLET 3 0 0 3 
BUTALBITAL-CAFFEINE-ACETAMINOPHEN-
CODEINE CAPSULE 
1 0 0 1 
CLINDAMYCIN LOT 1 0 0 1 
CLOBETASOL PROPIONATE E 1 0 0 1 
CLOBETASOL SOL 0 2 0 2 
COLCHICINE TAB 0.6MG 0 2 0 2 
CONCERTA ER 36 MG TABLET 3 6 0 9 
CONCERTA ER 54 MG TABLET 3 0 0 3 
DAYTRANA 10 MG/9 HR PATCH 6 3 0 9 
DAYTRANA 30 MG/9 HOUR PATCH 3 6 0 9 
EPIDUO FORTE 0.3-2.5% GEL PUMP 6 6 0 12 
ESOMEPRAZOLE MAG DR 20 MG CAP 0 9 0 9 
GLATOPA INJ 40MG/ML 1 0 0 1 
GUAIFENESIN-CODEINE LIQUID 1 0 0 1 
HUMIRA 0 1 0 1 
HUMIRA PEN 3 0 0 3 
KEPPRA 500 MG TABLET 3 0 0 3 
LIVALO 1 MG TABLET 0 3 0 3 
LIVALO 2 MG TABLET 6 0 0 6 
LIVALO 4 MG TABLET 3 0 0 3 
NEXIUM 2 0 0 2 
QUILLICHEW ER 40 MG CHEW TAB 3 0 0 3 
RELPAX 1 0 0 1 
VIMPAT 100 MG TABLET 12 0 0 12 
VIMPAT 150 MG TABLET 3 0 0 3 
VYVANSE CHEW TAB 10MG, 20MG, 30MG, 40MG, 
50MG, 60MG 
22 0 0 22 
XOSPATA 1 0 0 1 
ZOMIG 1 0 0 1 
TOTAL 100 93 0 193 
 
 
 
